Trading Summary - February 8. Another day - another PR -

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
168
Trading Summary - February 8.

Another day - another PR - albeit with nothing new for long-term close followers of the evolving $SFLM story.

The huge new interest in the main OTC market top trader rooms on Telegram and on iHub seen on Friday and Monday continued today.

With many traders already having what they want for trading throughout 2022, new interest failed to hit across asks .0021 > .0025 and so the usual pattern seen all last year spooled up with a combination of walked down asks from low level flippers, holdback attempts from any shorts using small paint downs, and in my opinion some very evident wash trading between MMs selling for legacy debt holders and MMs buying for institutional level investors that wanted say $10K > $15K worth at market prices - you could spot where mirrored numbers added up precisely without coming off the bid or being added to the ask when bought. While new interest could get in on the bid or a walked down ask below .0020, this disincentivized ask hitting higher.

All trades were in the same bottom range - less than 25% of target price .02+ range (ie anything under .0052).

There were quite a few for 2M > 5M+ buys - but at a single price - not yet across several asks at the open that are crucial to getting the breakout to the .01 > .02+ range started.

None of the asks are of any significance to hinder a quick break above .0030 towards the .01 > .02 range needed for OTCQB uplisting - and as appropriate to its $10.241M revenue market cap.

As shown in the report for December 31, 2021, the vast majority of shares are held with a cost basis under .0052 now with the balance above held by longs who didn't sell for a tax loss as it is self-evident the price should be going above .02 at some point in 2022.

Overall, 79M shares were bought today - .0016 > .0021.

New interest traders / alerters + long-term traders with significant followings as at February 6 numbered at least 186 - up 21 in the last 7 days - and 31 traders commenting on iHub.

Particular points they like are:

- Real revenue of $10.241M in 2021.

- Revenue growth of 34.75% in 2021 - beating the target of 30%.

- Operating profit achieved in 2021 Q3.

- $49K in cash available for inventory purchases at end-Q3.

- Assets of $1.398M at end-Q3.

- Revenue of $1.231M in 2022 Weeks 1-5 - which equates pro-rata to $12.837M for the year not including the additional revenue known to be coming from the NFT Division and from any acquisitions under the Collectibles Marketplace Strategy.

- Low Unrestricted O/S of 837M - with none added in the last 3+ months.

- How thin it is into the .01 > .02 range.

- Multiple catalysts ahead throughout 2022.

On the next run over .01, the degree to which $SFLM penetrates up towards .02+ will depend on how many of these new followers take profits above .01.

Either way, longs who follow my strategy will be keeping their core holding for the OTCQB uplisting - which will require sustaining prices above a .01 bid - and also some for when all 9 elements reach the same revenue level anticipated by the CEO.

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy would be in the .063 > .1100 range in future years when they manage to get all 9 elements in the plan to the performance level of the existing SFLMaven eBay business (plus remember more platforms coming as well).

On $SFLM, the larger the inventory of shares acquired below .0050, the more that will be available to trade for 100% to 400% in the .01 > .0150 range on the next run to that level - whenever that may be - whilst also retaining a significant core converted to free for OTCQB uplisting and the planned 8 x 2021 revenue under the Collectibles Marketplace Strategy.

Remember that the price difference between .0020 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .063 > .1100.

Every 1M bought at .0050 is worth a $7K profit at .0120, $10K profit at .0150, $15K profit at .02, $57K profit at .074 or $102.5K profit at .1075.

All that matters is who got what where - charts are irrelevant - and denying as many shares under .01 as possible to the institutional level new interest that PRs + improving financials + MZ Group though investor symposiums are expected to bring in over the days, weeks and months ahead in 2022.

Latest DD - updated February 6 - here:

https://investorshangout.com/post/view?id=6337287

$SFLM was the #1 Top Profit Pick and #1 Top Banked Profit stock of 2021 on my Watch List.

It is also my #1 Top Profit Pick for the whole of 2022.

I will not necessarily be doing a trading summary every day - unless there are undue manipulation attempts - as the ticker is firmly under control and just awaiting the next run into the .01 > .02 range.

Now that the 2022 PR campaign started on February 1, watch for future PRs on expansion under the Collectibles Marketplace Startegy, updates on the NFT Division , entry into the Metaverse and cryptocurrencie s markets and OTCQB uplisting.

13th CEO Video here:

https://vimeo.com/673267050

The Share Structure was updated after the close on January 20 - again showing no change and confirming no dilution for 3+ months - with the Unrestricted O/S remaining at a low 837M.

Week 6 revenue at "Buy It Now" prices ahead of the auction is $13,392 to February 8 11:07.

https://www.ebay.com/sch/i.html?_sofindtype=0...=1&rt=

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Data Center Transformers on the Brink of a Boom

Updated Category News Views 272

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 50

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
Essity's SEK 850m Bet: Expanding Lilla Edet Facility

Updated Category News Views 99

Essity Doubling Down on Hygiene Hygiene is something you can't compromise on, and Essity gets that. They're shelling out a cool SEK 850 million into their production facility at Lilla Edet in Sweden—no small change, even in the grand scheme of corporate investment. Why the Massive Investment? It's not just about throwing money around; this move is strategic. Essity’s...

Continue Reading
OI Investors Crack Down: Class Action Filing Looms

Updated Category News Views 183

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 24

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Eve Air Mobility's Vector System Proves Its Worth

Updated Category News Views 84

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 107

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
SciGround Launches: A Game-Changer in Research Verification

Updated Category News Views 148

Unshackling Research Verification from the Model Folks, here's the big one—Licklider, Inc. from Tokyo lobbed a curveball with their new player in town: SciGround. This platform takes the reins on mathematically verifying AI-driven research, which is something you'll want to keep an eye on if you're at all interested in AI or research replication. Why SciGround Gets My...

Continue Reading
JardogsHealth Taps Industry Titans for Growth Council

Updated Category News Views 99

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Continue Reading
Dahua's Pro Challenge 2026: Bridging Expertise Globally

Updated Category News Views 90

Celebrating Global Installer Expertise Dahua Technology took to the stage in Hangzhou for the Pro Challenge 2026, a shindig pulling installer partners from every corner of the globe. This wasn't just a tech jamboree; it was a tip of the hat to those on the ground who make Dahua's AIoT solutions tick. You know the drill: hands-on demos, tech showcases, and a whole lot of...

Continue Reading

Top 5 Most Recently Viewed Articles

AI’s Dual Nature: Growth Potential or Path to Collapse?

Updated Category News Views 242

The Dichotomy of AI: Catalyst for Growth or Collapse? Yes, AI is a catalyst, though what it catalyzes remains uncertain. The prevailing narrative suggests that our foremost challenge is the need for affordable energy to support the burgeoning data centers of AI technology. Fortunately, solutions are emerging, including the construction of modular nuclear power plants and...

Continue Reading
Ponche Kuba Refreshes Its Look While Keeping Original Flavor

Updated Category News Views 280

Exciting New Look for Ponche Kuba Today marks an exciting chapter in the world of liqueurs as Ponche Kuba unveils its new packaging design, an evolution of its iconic Caribbean rum cream liqueur. Since its inception in 1942 by Don Jaime A. J. Sprock, Ponche Kuba has maintained a loyal following due to its unique flavor and quality. Although the aesthetic has transformed,...

Continue Reading
Unlocking Crypto Success: Double Bonuses and 100x Leverage

Updated Category News Views 129

BexBack Introduces Exciting Crypto Trading Offers BexBack is revolutionizing the cryptocurrency trading landscape with dynamic offers designed for traders looking to capitalize on recent market volatility. Following significant developments in the industry, BexBack has stepped up to provide traders with exceptional options, making it easier than ever to start trading....

Continue Reading
Innovative Partnership Between eMolecules and Optic for Drug Discovery

Updated Category News Views 75

Transforming Drug Discovery with AI Collaboration In an exciting development for the pharmaceutical industry, eMolecules, a leading chemical sourcing company, has joined forces with Optic, a digital biology firm. This collaboration aims to revolutionize the drug discovery process by leveraging the power of artificial intelligence. Together, these companies are creating a...

Continue Reading
Vivani Medical Advances Canine Health with Expanded Collaboration

Updated Category News Views 214

Collaborative Efforts to Enhance Canine Metabolic Health Vivani Medical, Inc. and Okava Pharmaceuticals, Inc. have announced an exciting expansion of their partnership, aiming to enhance the metabolic health and longevity of dogs. With a mutual vision for veterinary medicine, the collaboration focuses on the development of OKV-119, a long-acting GLP-1 therapy designated...

Continue Reading